Panagora Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,537
Closed -$390K 1488
2022
Q1
$390K Hold
10,537
﹤0.01% 1294
2021
Q4
$479K Buy
10,537
+4,470
+74% +$233K ﹤0.01% 1234
2021
Q3
$384K Hold
6,067
﹤0.01% 1415
2021
Q2
$555K Sell
6,067
-1,339
-18% -$106K ﹤0.01% 1283
2021
Q1
$504K Buy
+7,406
New +$575K ﹤0.01% 1326
2020
Q4
Sell
-1,142
Closed -$43K 2818
2020
Q3
$43K Hold
1,142
﹤0.01% 2054
2020
Q2
$40K Hold
1,142
﹤0.01% 2030
2020
Q1
$25K Buy
1,142
+207
+22% +$4.64K ﹤0.01% 1997
2019
Q4
$20K Buy
+935
New +$21.4K ﹤0.01% 2041
2019
Q1
Sell
-76
Closed -$2K 2510
2018
Q4
$2K Hold
76
﹤0.01% 2405
2018
Q3
$2K Sell
76
-5,144
-99% -$96.3K ﹤0.01% 2368
2018
Q2
$64K Sell
5,220
-16,228
-76% -$186K ﹤0.01% 1985
2018
Q1
$171K Hold
21,448
﹤0.01% 1710
2017
Q4
$157K Sell
21,448
-20,537
-49% -$128K ﹤0.01% 1745
2017
Q3
$155K Sell
41,985
-10,069
-19% -$21.1K ﹤0.01% 1773
2017
Q2
$58K Buy
52,054
+28,228
+118% +$30K ﹤0.01% 2027
2017
Q1
$33K Buy
+23,826
New +$53.1K ﹤0.01% 2081

Other funds holding CDNA

Panagora Asset Management's CDNA Position: Q2 2022 in Review

Panagora Asset Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 10,537 shares — an estimated $390K sold.

Panagora Asset Management first reported a position in CDNA in Q1 2017 and held it in 17 quarters. The position peaked at $555K in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Panagora Asset Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Panagora Asset Management sold 10,537 CareDx shares in Q2 2022, an estimated $390K.
  • Panagora Asset Management first reported a position in CareDx in Q1 2017 and held it in 17 quarters.
  • Panagora Asset Management's CareDx position peaked at $555K in Q2 2021.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.